Valink Therapeutics

Valink Therapeutics is a biotechnology company developing first-class bispecific antibody-drug conjugates (bsADC) and other modalities to improve patient outcomes. Valink's proprietary discovery platform and V-Gate™ approach address key challenges of current technologies by expanding the toolbox of available methods for bispecific antibody therapies and bispecific ADCs, unlocking fine-tuned target control, functional outcomes, and an improved therapeutic index. In addition to bsADC, the company has also developed proprietary protein technologies for multispecific or multifunctional ADCs, multivalent agonists, and more.